Chirag Shah

Also affiliated with Bridgeport Hospital

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study”.

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study

European Journal of Gynaecological Oncology(2023)10.22514/ejgo.2023.002

N/A

0.385DataRank · unranked

12 citations

Tsung-Chiung Wu, E Barber, Minh Dao, Emese Zsíros, Renata R. Urban +8 more

Race and Ethnicity Representation in Phase 2/3 Oncology Clinical Trial Publications

JAMA Health Forum(2024)10.1001/jamahealthforum.2024.1388

N/A

0.360DataRank · unranked

10 citations

Ryan Benavente, Jonathan J. Shih, Megan Y. Gimmen, Paul Tominez, Kāʻeo Kekumano +12 more